Clinical trial of the p38 MAP kinase inhibitor dilmapimod in neuropathic pain following nerve injury. (Q54589616)

1 June 2018

title

Clinical trial of the p38 MAP kinase inhibitor dilmapimod in neuropathic pain following nerve injury. (English)

1 reference

1 June 2018

0 references

Praveen Anand

1

1 reference

1 June 2018

Ravikiran Shenoy

2

1 reference

1 June 2018

Joanne E Palmer

3

1 reference

1 June 2018

Amanda J Baines

4

1 reference

1 June 2018

Robert Y K Lai

5

1 reference

1 June 2018

Jonathan Robertson

6

1 reference

1 June 2018

Nick Bird

7

1 reference

1 June 2018

Thor Ostenfeld

8

1 reference

1 June 2018

Boris A Chizh

9

1 reference

1 June 2018

publication date

14 May 2011

1 reference

1 June 2018

published in

European Journal of Pain

1 reference

1 June 2018

volume

15

1 reference

1 June 2018

issue

10

1 reference

1 June 2018

page(s)

1040-1048

1 reference

1 June 2018

Heat shock protein 27 functions in inflammatory gene expression and transforming growth factor-beta-activated kinase-1 (TAK1)-mediated signaling.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.04.005

TRPA1 receptor localisation in the human peripheral nervous system and functional studies in cultured human and rat sensory neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.04.005

The potential role of nerve growth factor (NGF) in painful neuromas and the mechanism of pain relief by their relocation to muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.04.005

Current options for nonsurgical management of carpal tunnel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.04.005

Evaluation of the efficacy and safety of pamapimod, a p38 MAP kinase inhibitor, in a double-blind, methotrexate-controlled study of patients with active rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.04.005

Randomized, double-blind, placebo-controlled, dose-response, and preclinical safety study of transforaminal epidural etanercept for the treatment of sciatica.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.04.005

Efficacy, pharmacodynamics, and safety of VX-702, a novel p38 MAPK inhibitor, in rheumatoid arthritis: results of two randomized, double-blind, placebo-controlled clinical studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.04.005

Incidence rates and treatment of neuropathic pain conditions in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.04.005

Prostanoid receptor EP1 and Cox-2 in injured human nerves and a rat model of nerve injury: a time-course study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.04.005

Cyclooxygenase-2 (Cox-2) in injured human nerve and a rat model of nerve injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.04.005

Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.04.005

Differential expression of the capsaicin receptor TRPV1 and related novel receptors TRPV3, TRPV4 and TRPM8 in normal human tissues and changes in traumatic and diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.04.005

The evidence for pharmacological treatment of neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.04.005

Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.04.005

Increased capsaicin receptor TRPV1 in skin nerve fibres and related vanilloid receptors TRPV3 and TRPV4 in keratinocytes in human breast pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.04.005

Gabapentin in traumatic nerve injury pain: a randomized, double-blind, placebo-controlled, cross-over, multi-center study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.04.005

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.04.005

p38 MAPK activation by NGF in primary sensory neurons after inflammation increases TRPV1 levels and maintains heat hyperalgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.04.005

p38 MAPK, microglial signaling, and neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.04.005

Neuronal plasticity and signal transduction in nociceptive neurons: implications for the initiation and maintenance of pathological pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.04.005

Duloxetine for the management of diabetic peripheral neuropathic pain: evidence-based findings from post hoc analysis of three multicenter, randomized, double-blind, placebo-controlled, parallel-group studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.04.005

Local corticosteroid injection for carpal tunnel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.04.005

TRPA1 induced in sensory neurons contributes to cold hyperalgesia after inflammation and nerve injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.04.005

Role of mitogen-activated protein kinase activation in injured and intact primary afferent neurons for mechanical and heat hypersensitivity after spinal nerve ligation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.04.005

Single-dose pharmacokinetics and pharmacodynamics of RWJ 67657, a specific p38 mitogen-activated protein kinase inhibitor: a first-in-human study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.04.005

Microglial signalling cascades in neurodegenerative disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.04.005

Rheumatoid arthritis therapy after tumor necrosis factor and interleukin-1 blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.04.005

Inhibition of p38 mitogen-activated protein kinase reduces inflammation after coronary vascular injury in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.04.005

Gabapentin in neuropathic pain syndromes: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.04.005

A randomized, placebo-controlled study of the effects of the p38 MAPK inhibitor SB-681323 on blood biomarkers of inflammation in COPD patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.04.005

TRPV3 is a temperature-sensitive vanilloid receptor-like protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.04.005

Antinociceptive action of a p38alpha MAPK inhibitor, SD-282, in a diabetic neuropathy model

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.04.005

Peripheral and central p38 MAPK mediates capsaicin-induced hyperalgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.04.005

Neuropathic pain and spinal microglia: a big problem from molecules in "small" glia

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.04.005

Activation of p38 mitogen-activated protein kinase in spinal hyperactive microglia contributes to pain hypersensitivity following peripheral nerve injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.04.005

10.1016/J.EJPAIN.2011.04.005

21 January 2018

Identifiers

DOI

1 reference

1 June 2018

PubMed ID

21576029

1 reference

1 June 2018